Skip to main content
. 2023 Feb 28;18(2):e0282440. doi: 10.1371/journal.pone.0282440

Table 5. Indication for prednisolone in Australian dogs receiving ≥2mg/kg/day of prednisolone (n = 77).

Body system Primary differential or clinical indication Number of dogs
Integument Inflammatory skin or ear disease 28
Lupus erythematosus 2
Urticaria 1
Mammary carcinoma with dermatitis 1
Uncharacterised dermopathy (vesicles) 1
Sterile nodular panniculitis 1
Ear mass 1
Cutaneous mass 1
Neurological Meningitis 5
Steroid responsive cerebellitis 2
Neck or spinal pain, suspected disk disease 2
Seizures 1
Steroid responsive meningitis arteritis 1
Paresis and spinal pain (no differential) 1
Acute blindness 1
Haematopoietic Immune mediated haemolytic anaemia 6
Lymphoma 3
Immune mediated thrombocytopenia 2
Concurrent immune mediated haemolytic anaemia and immune mediated thrombocytopenia 1
Chronic leukaemia 1
Respiratory Upper airway obstruction 3
Sneezing 2
Coughing 1
Epistaxis and suspected nasal neoplasia 1
Unknown 4
Gastrointestinal Vomiting, suspected neoplasia 1
Oral mass lesion 1
Ocular Trauma and secondary hyphaemia 1
Musculoskeletal Immune mediated polyarthritis 1